Regulatory T Cells in Autoimmune Hepatitis:
Increased in Number, but Functionally Impaired

A recent study has found that, although regulatory T cells (Tregs)?key cells responsible for maintaining immune balance?are increased in patients with autoimmune hepatitis, their actual immunosuppressive function is, in fact, diminished. This finding highlights the need for new immune modulation approaches that go beyond the limitations of existing treatment strategies.


On January 27, Seoul St. Mary's Hospital announced that a research team led by Professor Sung Pilsoo from the Department of Gastroenterology analyzed the blood and liver tissue of untreated autoimmune hepatitis patients and discovered that, while the number of regulatory T cells was elevated, these cells were functionally unstable and their immunosuppressive capacity was insufficient. The results were published in the international journal 'Hepatology International.'

Figure showing impaired regulatory T cell (Treg) function in patients with autoimmune hepatitis. Seoul St. Mary's Hospital

Figure showing impaired regulatory T cell (Treg) function in patients with autoimmune hepatitis. Seoul St. Mary's Hospital

View original image

Regulatory T cells suppress excessive immune responses and maintain immune homeostasis. Recently, the Nobel Prize in Physiology or Medicine was awarded for the discovery of regulatory T cells and the elucidation of immune tolerance mechanisms, drawing renewed attention to the dysfunction of these cells as a key factor in cancer and autoimmune disease treatment strategies.


The research team observed that the number of regulatory T cells increased in proportion to the severity of liver inflammation in autoimmune hepatitis patients. However, in co-culture experiments, regulatory T cells derived from patients showed significantly reduced immunosuppressive function compared to those from healthy individuals. This indicates that a simple increase in cell number is not sufficient to maintain immune regulatory function, and that the 'functional stability' of regulatory T cells is a critical factor influencing clinical outcomes.


Single-cell RNA sequencing analysis also revealed that regulatory T cells in autoimmune hepatitis patients exhibited increased expression of the IL-7 receptor, which is associated with immune cell activation and inflammation. This suggests that regulatory T cells are in an unstable state, losing their original suppressive function and acquiring characteristics similar to effector T cells.


In the blood, regulatory T cells showed decreased expression of Helios, a marker reflecting cellular stability. The study also confirmed that increased levels of inflammatory cytokines, such as IL-6 and TNF-α, may contribute to the impaired function of regulatory T cells by creating a pro-inflammatory microenvironment.


Autoimmune hepatitis is difficult to diagnose early, as initial symptoms such as fatigue and digestive discomfort are hard to distinguish from common ailments. If treatment is delayed, the disease can progress to cirrhosis; however, with early diagnosis and appropriate therapy, the prognosis is relatively favorable.


Professor Sung stated, "The significance of this study lies in demonstrating that it is the functional stability, rather than the number, of regulatory T cells that determines immune dysregulation in autoimmune hepatitis. There is a need for new immune modulation therapies that go beyond simple immunosuppression and focus on restoring regulatory T cell function."



He added, "Unlike in other countries, a high proportion of autoimmune hepatitis patients in Korea are women in their 60s, and there is growing interest in the potential association with vaccination. It is necessary to develop treatment strategies and conduct follow-up research tailored to the characteristics of Korean patients."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing